Low vitamin K status, high sclerostin and mortality risk of stable coronary heart disease patients.
Mayer O, Bruthans J, Seidlerová J, Gelžinský J, Kučera R, Karnosová P, Mateřánková M, Rychecká M, Wohlfahrt P, Cífková R, Filipovský J, Vermeer C.
Mayer O, et al. Among authors: cifkova r.
Biomark Med. 2021 Nov;15(16):1465-1477. doi: 10.2217/bmm-2021-0168. Epub 2021 Oct 20.
Biomark Med. 2021.
PMID: 34668399
Clinical Trial.